benserazide has been researched along with Dystonic Disorders in 3 studies
Benserazide: An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.
benserazide : A carbohydrazide that results from the formal condensation of the carboxy group of DL-serine with the primary amino group of 4-(hydrazinylmethyl)benzene-1,2,3-triol. An aromatic-L-amino-acid decarboxylase inhibitor (DOPA decarboxylase inhibitor) that does not enter the central nervous system, it is used as its hydrochloride salt as an adjunct to levodopa in the treatment of parkinsonism. By preventing the conversion of levodopa to dopamine in the periphery, it causes an increase in the amount of levodopa reaching the central nervous system and so reduces the required dose. Benserazide has no antiparkinson actions when given alone.
Dystonic Disorders: Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, HY | 1 |
| Feng, JY | 1 |
| Yue, XJ | 1 |
| Shan, L | 1 |
| Jia, FY | 1 |
| Grötzsch, H | 1 |
| Schnorf, H | 1 |
| Morris, MA | 1 |
| Moix, I | 1 |
| Horvath, J | 1 |
| Prilipko, O | 1 |
| Burkhard, PR | 1 |
| Casseron, W | 1 |
| Genton, P | 1 |
1 review available for benserazide and Dystonic Disorders
| Article | Year |
|---|---|
Dopa-responsive dystonia caused by tyrosine hydroxylase deficiency: Three cases report and literature review.
Topics: Benserazide; Child; Child, Preschool; Dopamine Agents; Dystonic Disorders; Humans; Levodopa; Male; T | 2020 |
2 other studies available for benserazide and Dystonic Disorders
| Article | Year |
|---|---|
Phenotypic heterogeneity of dopa-responsive dystonia in monozygotic twins.
Topics: Adult; Benserazide; Biopterins; Clubfoot; Dihydroxyphenylalanine; Disease Progression; Diseases in T | 2004 |
DOPA-sensitive dystonia-plus syndrome.
Topics: Adolescent; Benserazide; Brain; Child; Child Behavior Disorders; Child, Preschool; Craniofacial Abno | 2005 |